Hypertension and Cardiovascular Disease Risk Among Individuals With Versus Without HIV

Mohammed Siddiqui1, Lonnie Hannon2, Zhixin Wang3

  • 1Department of Medicine (M.S., S.O., S.L.H., E.T.O.), University of Alabama at Birmingham, Birmingham, AL.

Insights

Hypertension increases cardiovascular disease (CVD) risk in people with and without HIV. The risk of acute myocardial infarction (AMI) is notably higher for individuals with HIV and hypertension.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Individuals with HIV often have hypertension, leading to a high incidence of cardiovascular disease (CVD).
  • Understanding the differential impact of hypertension on CVD risk in HIV-positive populations is crucial for targeted interventions.

Purpose of the Study:

  • To investigate whether the association between hypertension and CVD risk differs between individuals with and without HIV.
  • To compare the incidence of acute myocardial infarction (AMI), stroke, and heart failure in relation to hypertension in these two groups.

Main Methods:

  • Analysis of a large cohort of US adults with (108,980) and without (435,920) HIV from 2011-2019 using the Marketscan database.
  • Matched analysis with a 1:4 ratio, focusing on incident CVD events (AMI, stroke, heart failure) identified via validated claims-based algorithms.
  • Multivariable adjustment and interaction analysis to assess the effect of hypertension on CVD risk stratified by HIV status.

Main Results:

  • Hypertension was associated with increased CVD risk in both HIV-positive and HIV-negative individuals.
  • A significantly stronger association between hypertension and AMI was observed in individuals with HIV (HR 1.70) compared to those without (HR 1.35).
  • No significant effect modification by HIV status was found for the association of hypertension with stroke or heart failure.

Conclusions:

  • Hypertension is linked to elevated risks of CVD, AMI, stroke, and heart failure in both HIV-positive and HIV-negative individuals.
  • The study highlights a particularly amplified risk of AMI associated with hypertension among individuals living with HIV.
  • Emphasizes the critical need to manage hypertension effectively in the HIV-positive population due to their heightened CVD risk.
Abstract

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
31
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
36
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.2K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
44
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
65
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
37